Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs GSK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON GSK PHARMA BIOCON /
GSK PHARMA
 
P/E (TTM) x 19.7 62.1 31.7% View Chart
P/BV x 1.8 18.8 9.6% View Chart
Dividend Yield % 0.6 1.7 34.4%  

Financials

 BIOCON    GSK PHARMA
EQUITY SHARE DATA
    BIOCON
Mar-23
GSK PHARMA
Mar-23
BIOCON /
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs3881,684 23.0%   
Low Rs1921,231 15.6%   
Sales per share (Unadj.) Rs93.1191.9 48.5%  
Earnings per share (Unadj.) Rs5.435.9 14.9%  
Cash flow per share (Unadj.) Rs14.639.8 36.8%  
Dividends per share (Unadj.) Rs1.5032.00 4.7%  
Avg Dividend yield %0.52.2 23.6%  
Book value per share (Unadj.) Rs146.5102.9 142.4%  
Shares outstanding (eoy) m1,200.60169.41 708.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.17.6 41.0%   
Avg P/E ratio x54.140.6 133.1%  
P/CF ratio (eoy) x19.836.7 54.0%  
Price / Book Value ratio x2.014.2 14.0%  
Dividend payout %28.089.2 31.4%   
Avg Mkt Cap Rs m347,814246,858 140.9%   
No. of employees `000NANA-   
Total wages/salary Rs m21,8105,950 366.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m111,74232,517 343.6%  
Other income Rs m7,6811,007 763.1%   
Total revenues Rs m119,42333,524 356.2%   
Gross profit Rs m16,6118,033 206.8%  
Depreciation Rs m11,131658 1,692.5%   
Interest Rs m4,19018 23,123.6%   
Profit before tax Rs m8,9718,364 107.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,5412,288 111.1%   
Profit after tax Rs m6,4306,076 105.8%  
Gross profit margin %14.924.7 60.2%  
Effective tax rate %28.327.4 103.6%   
Net profit margin %5.818.7 30.8%  
BALANCE SHEET DATA
Current assets Rs m123,34024,943 494.5%   
Current liabilities Rs m85,10713,264 641.7%   
Net working cap to sales %34.235.9 95.3%  
Current ratio x1.41.9 77.1%  
Inventory Days Days12997 132.6%  
Debtors Days Days117216 54.1%  
Net fixed assets Rs m394,0786,988 5,639.6%   
Share capital Rs m6,0031,694 354.4%   
"Free" reserves Rs m169,92615,735 1,079.9%   
Net worth Rs m175,92917,430 1,009.4%   
Long term debt Rs m152,9050-   
Total assets Rs m517,41831,930 1,620.5%  
Interest coverage x3.1462.6 0.7%   
Debt to equity ratio x0.90-  
Sales to assets ratio x0.21.0 21.2%   
Return on assets %2.119.1 10.8%  
Return on equity %3.734.9 10.5%  
Return on capital %4.048.1 8.3%  
Exports to sales %3.10-   
Imports to sales %6.048.1 12.4%   
Exports (fob) Rs m3,467NA-   
Imports (cif) Rs m6,65415,630 42.6%   
Fx inflow Rs m3,4671,622 213.8%   
Fx outflow Rs m6,65415,630 42.6%   
Net fx Rs m-3,187-14,008 22.8%   
CASH FLOW
From Operations Rs m18,5254,842 382.6%  
From Investments Rs m-142,8188,079 -1,767.9%  
From Financial Activity Rs m130,487-15,433 -845.5%  
Net Cashflow Rs m6,411-2,512 -255.2%  

Share Holding

Indian Promoters % 40.4 0.0 -  
Foreign collaborators % 20.3 75.0 27.0%  
Indian inst/Mut Fund % 21.1 11.6 181.9%  
FIIs % 6.6 2.9 223.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.4 25.0 157.4%  
Shareholders   434,339 114,663 378.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Biocon vs GSK Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Biocon vs GSK Pharma Share Price Performance

Period Biocon GSK Pharma S&P BSE HEALTHCARE
1-Day 3.04% 3.05% 1.18%
1-Month -2.42% -9.96% -0.75%
1-Year 30.66% 52.31% 61.82%
3-Year CAGR -13.51% 10.81% 18.16%
5-Year CAGR -2.70% 8.40% 19.79%

* Compound Annual Growth Rate

Here are more details on the Biocon share price and the GSK Pharma share price.

Moving on to shareholding structures...

The promoters of Biocon hold a 60.6% stake in the company. In case of GSK Pharma the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Biocon and the shareholding pattern of GSK Pharma.

Finally, a word on dividends...

In the most recent financial year, Biocon paid a dividend of Rs 1.5 per share. This amounted to a Dividend Payout ratio of 28.0%.

GSK Pharma paid Rs 32.0, and its dividend payout ratio stood at 89.2%.

You may visit here to review the dividend history of Biocon, and the dividend history of GSK Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.